Log In
Print
BCIQ
Print
Print this Print this
 

anti-OX40 (MOXR0916, RG7888)

  Manage Alerts
Collapse Summary General Information
Company Genentech Inc.
DescriptionHuman mAb against OX40 ligand (OX40L)
Molecular Target OX40 ligand (OX40L) (CD134L)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase II/III
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today